application) The main objectives of this core are to provide a number of specialized peptides and molecular probes in a cost-effective manner. Many studies performed at CURE utilize peptide reagents. core investigators are trained in how to make, store, dilute and evaluate peptides properly under experimental conditions. The core helps in characterization of natural or synthetic peptides by amino acid analysis, high performance capillary electrophoresis, high performance liquid chromatography (HPLC), mass spectral analysis and microsequence analysis. The core also provides training, reagents and equipment facilities for the radioimmunoassay as well. Investigators are also provided standard or heavily used peptides either in their native form or modified to impart features such as fluorescence or labeling sites. Molecular probes such as oligodeoxyribonucleotides or cDNA probes are provided and analyzed for appropriate quality to ensure that the acquired or custom made probes are of the highest quality. The core is housed in three different laboratories: The Peptide Biochemistry Laboratory (VA); The Nucleic Acid Probes Laboratory (VA) and the Peptide Synthesis and Purification Laboratory (UCLA). The core laboratories are well equipped with all the basic equipment, such as HPLC, dual wavelength UV detector, variable wavelength UV detector, gamma counter, a variety of HPLC columns and centrifuges. Other specialized techniques, such as microsequence, NMR, circular dichroism, mass spectrometry measurements, are performed at various other UCLA laboratories coordinated by the core. The core facilities are currently being utilized by 25 CURE investigators in their projects, and the utilization had resulted in 87 publications during the previous funding period.

Project Start
2000-06-01
Project End
2000-11-30
Budget Start
Budget End
Support Year
11
Fiscal Year
2000
Total Cost
$293,330
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Koon, Hon Wai; Wang, Jiani; Mussatto, Caroline C et al. (2018) Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-?B Activity. Antimicrob Agents Chemother 62:
Wang, Jiani; Ghali, Sally; Xu, Chunlan et al. (2018) Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Gastroenterology 154:1737-1750
Manatsathit, Wuttiporn; Khrucharoen, Usah; Jensen, Dennis M et al. (2018) Laparotomy and intraoperative enteroscopy for obscure gastrointestinal bleeding before and after the era of video capsule endoscopy and deep enteroscopy: A tertiary center experience. Am J Surg 215:603-609
Rankin, Carl Robert; Theodorou, Evangelos; Man Law, Ivy Ka et al. (2018) Identification of novel mRNAs and lncRNAs associated with mouse experimental colitis and human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 315:G722-G733
Park, S H; Naliboff, B D; Shih, W et al. (2018) Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 30:
Dong, Tien; Pisegna, Joseph (2018) Passing the ""Acid Test"": Do Proton Pump Inhibitors Affect the Composition of the Microbiome? Dig Dis Sci :
Basheer, Wassim A; Fu, Ying; Shimura, Daisuke et al. (2018) Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia/reperfusion injury. JCI Insight 3:
Jacobs, Jonathan P; Dong, Tien S; Agopian, Vatche et al. (2018) Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatol Res :
Sala-Rabanal, Monica; Ghezzi, Chiara; Hirayama, Bruce A et al. (2018) Intestinal absorption of glucose in mice as determined by positron emission tomography. J Physiol 596:2473-2489
Lin, De-Chen; Dinh, Huy Q; Xie, Jian-Jun et al. (2018) Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas. Gut 67:1769-1779

Showing the most recent 10 out of 1097 publications